Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

National Taiwan University

Status and phase: Unknown; Phase 4

Conditions: Liver Disease

Treatments: Drug: morphine and glucagon

Study type: Interventional

Funder types: Other

Identifiers

NCT00155376

940104

Details and patient eligibility

About

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Full description

Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile secretion and dilatation of bile duct. We conduct this randomized double blinded study to evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.

Sex: All

Ages: 20 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• normal volunteer
• living liver donor

Exclusion criteria

• COPD
• chronic liver disease
• hypersensitive to glucagon
• DM
• insulinoma
• glucagonoma
• pregnancy

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind